Skip to main content
. 2013 Oct 18;8(10):e76928. doi: 10.1371/journal.pone.0076928

Figure 1. Analysis of blood NK cells from donors and melanoma patients.

Figure 1

(A) Proportions (left) and absolute numbers (right) of NK cells among PBMC from donors and melanoma patients stratified according to their clinical stages. (B) Proportions of CD56dim and CD56bright cells among the NK cell population in donors and patients. Statistical analysis was assessed by non-parametric Kruskal-Wallis (K-W) test (n.s = not significant).